Stryker - 41 Year Stock Price History | SYK
Historical daily share price chart and data for Stryker since 1984 adjusted for splits and dividends. The latest closing stock price for Stryker as of August 26, 2025 is 394.33.
- The all-time high Stryker stock closing price was 403.53 on July 25, 2025.
- The Stryker 52-week high stock price is 406.19, which is 3% above the current share price.
- The Stryker 52-week low stock price is 329.16, which is 16.5% below the current share price.
- The average Stryker stock price for the last 52 weeks is 376.08.
| Stryker Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 379.2531 | 357.1290 | 403.5300 | 336.6500 | 394.3300 | 10.01% |
| 2024 | 344.4322 | 292.2210 | 389.5060 | 289.9620 | 358.4530 | 21.34% |
| 2023 | 274.8202 | 240.1200 | 299.3110 | 240.1200 | 295.4070 | 23.80% |
| 2022 | 225.1148 | 258.7020 | 267.7140 | 183.5280 | 238.6170 | -7.42% |
| 2021 | 245.7778 | 228.0860 | 268.6240 | 210.9000 | 257.7380 | 10.22% |
| 2020 | 189.8050 | 198.3620 | 233.8300 | 119.2340 | 233.8300 | 18.17% |
| 2019 | 185.9396 | 144.1240 | 208.0070 | 142.2210 | 197.8810 | 35.33% |
| 2018 | 154.5323 | 145.5680 | 166.2320 | 134.8070 | 146.2220 | 2.43% |
| 2017 | 128.0718 | 108.7560 | 146.8190 | 107.2260 | 142.7470 | 30.84% |
| 2016 | 99.9126 | 80.8597 | 111.0900 | 78.6231 | 109.1020 | 30.69% |
| 2015 | 85.1654 | 83.1705 | 93.1805 | 79.7017 | 83.4826 | 0.01% |
| 2014 | 72.8830 | 65.0696 | 85.1805 | 65.0696 | 83.4714 | 27.41% |
| 2013 | 58.6373 | 47.9425 | 65.5143 | 47.9425 | 65.5143 | 39.29% |
| 2012 | 45.5506 | 43.1019 | 48.3024 | 42.2263 | 47.0330 | 12.11% |
| 2011 | 45.8130 | 45.4230 | 54.1531 | 36.6739 | 41.9541 | -6.12% |
| 2010 | 43.0294 | 42.8915 | 48.5518 | 35.4586 | 44.6907 | 7.90% |
| 2009 | 34.1747 | 33.8009 | 42.7984 | 25.5205 | 41.4195 | 26.71% |
| 2008 | 49.0065 | 59.6165 | 59.8028 | 29.5490 | 32.6881 | -45.99% |
| 2007 | 53.8495 | 44.4549 | 61.6820 | 44.4549 | 60.5237 | 36.17% |
| 2006 | 38.2080 | 35.8269 | 44.7210 | 32.8386 | 44.4468 | 24.53% |
| 2005 | 38.8042 | 38.6648 | 44.9554 | 31.8935 | 35.6903 | -7.69% |
| 2004 | 37.6774 | 33.4969 | 45.8543 | 33.3929 | 38.6648 | 13.73% |
| 2003 | 28.8074 | 27.1560 | 33.9968 | 24.0500 | 33.9968 | 26.87% |
| 2002 | 22.9540 | 22.8071 | 26.7967 | 18.1086 | 26.7967 | 15.20% |
| 2001 | 21.5039 | 19.3344 | 24.4704 | 17.5482 | 23.2614 | 15.58% |
| 2000 | 16.1588 | 13.5785 | 21.4476 | 10.1280 | 20.1261 | 45.56% |
| 1999 | 11.3658 | 10.7041 | 14.2102 | 8.8706 | 13.8267 | 26.68% |
| 1998 | 8.0766 | 7.3795 | 10.9148 | 6.2280 | 10.9148 | 47.91% |
| 1997 | 6.9281 | 5.8514 | 8.8141 | 4.9009 | 7.3795 | 25.06% |
| 1996 | 5.1322 | 5.1805 | 6.1920 | 4.1444 | 5.9008 | 13.90% |
| 1995 | 4.3606 | 3.5940 | 5.6222 | 3.5940 | 5.1805 | 42.92% |
| 1994 | 3.1400 | 2.7727 | 3.6723 | 2.3661 | 3.6248 | 30.15% |
| 1993 | 2.7040 | 3.7933 | 3.7933 | 2.1676 | 2.7851 | -27.75% |
| 1992 | 3.6071 | 4.6790 | 5.0360 | 2.6843 | 3.8548 | -21.73% |
| 1991 | 2.6356 | 1.4772 | 5.0484 | 1.3910 | 4.9252 | 220.09% |
| 1990 | 1.2617 | 1.2187 | 1.5941 | 0.9478 | 1.5387 | 26.26% |
| 1989 | 0.9108 | 0.6483 | 1.2187 | 0.6483 | 1.2187 | 83.35% |
| 1988 | 0.6937 | 0.6155 | 0.8124 | 0.6073 | 0.6647 | 15.72% |
| 1987 | 0.6956 | 0.5334 | 0.9519 | 0.4267 | 0.5744 | 9.37% |
| 1986 | 0.5343 | 0.3980 | 0.7099 | 0.3816 | 0.5252 | 33.33% |
| 1985 | 0.3418 | 0.2653 | 0.4021 | 0.2653 | 0.3939 | 46.92% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $149.436B | $22.595B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.514B | 26.91 |
| Boston Scientific (BSX) | United States | $155.747B | 37.14 |
| EssilorLuxottica (ESLOY) | France | $144.168B | 0.00 |
| Medtronic (MDT) | Ireland | $117.977B | 16.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.715B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.412B | 24.82 |
| ResMed (RMD) | United States | $41.845B | 29.93 |
| GE HealthCare Technologies (GEHC) | United States | $34.055B | 16.01 |
| Agilent Technologies (A) | United States | $33.846B | 22.07 |
| Koninklijke Philips (PHG) | Netherlands | $26.577B | 17.58 |
| Terumo (TRUMY) | Japan | $26.206B | 31.05 |
| Insulet (PODD) | United States | $23.159B | 77.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.260B | 13.53 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $16.271B | 0.00 |
| Baxter (BAX) | United States | $12.615B | 9.75 |
| Sunny Optical Technology (SNPTF) | China | $10.800B | 0.00 |
| Demant (WILYY) | Denmark | $8.121B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.048B | 29.56 |
| Lantheus Holdings (LNTH) | United States | $3.819B | 10.32 |
| Envista Holdings (NVST) | United States | $3.510B | 24.56 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Perrigo (PRGO) | Ireland | $3.272B | 8.17 |
| Prestige Consumer Healthcare (PBH) | United States | $3.231B | 14.34 |
| ICU Medical (ICUI) | United States | $3.106B | 21.15 |
| Haemonetics (HAE) | United States | $2.661B | 11.88 |
| LeMaitre Vascular (LMAT) | United States | $2.209B | 47.38 |
| Acuren (TIC) | United States | $2.126B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $2.005B | 0.00 |
| AtriCure (ATRC) | United States | $1.881B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.877B | 11.82 |
| Green Thumb Industries (GTBIF) | United States | $1.869B | 80.25 |
| Tilray Brands (TLRY) | Canada | $1.530B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.295B | 16.55 |
| AdaptHealth (AHCO) | United States | $1.249B | 17.75 |
| BioLife Solutions (BLFS) | United States | $1.229B | 2565.00 |
| Neogen (NEOG) | United States | $1.216B | 19.31 |
| InMode (INMD) | Israel | $0.921B | 8.52 |
| Kestra Medical Technologies (KMTS) | United States | $0.910B | 0.00 |
| Valneva SE (VALN) | France | $0.802B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.648B | 0.00 |
| SNDL (SNDL) | Canada | $0.631B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.613B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.593B | 0.00 |
| ZimVie (ZIMV) | United States | $0.535B | 20.61 |
| Surmodics (SRDX) | United States | $0.505B | 0.00 |
| Evolus (EOLS) | United States | $0.481B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.473B | 16.29 |
| CeriBell (CBLL) | United States | $0.419B | 0.00 |
| Owens & Minor (OMI) | United States | $0.396B | 3.51 |
| Sanuwave Health (SNWV) | United States | $0.366B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.345B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.331B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.302B | 0.00 |
| Omeros (OMER) | United States | $0.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.295B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Brainsway (BWAY) | Israel | $0.290B | 59.08 |
| High Tide (HITI) | Canada | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.275B | 20.85 |
| TriSalus Life Sciences (TLSI) | United States | $0.246B | 0.00 |
| Cerus (CERS) | United States | $0.245B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.243B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| Organigram Global (OGI) | Canada | $0.219B | 0.00 |
| Quanterix (QTRX) | United States | $0.217B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.193B | 16.13 |
| FitLife Brands (FTLF) | United States | $0.171B | 21.05 |
| Biote (BTMD) | United States | $0.160B | 5.30 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| Jin Medical (ZJYL) | China | $0.133B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| MacroGenics (MGNX) | United States | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.095B | 12.31 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.078B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Safety Shot (SHOT) | United States | $0.066B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 32.03 |
| Veru (VERU) | United States | $0.051B | 0.00 |
| Zynex (ZYXI) | United States | $0.051B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.045B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 34.92 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.36 |
| Trinity Biotech (TRIB) | Ireland | $0.028B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.012B | 0.00 |
| Sharps Technology (STSS) | United States | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |